Literature DB >> 25409785

Therapeutic potential of human adipose-derived stem cells in neurological disorders.

Keun-A Chang1, Jun-Ho Lee, Yoo-Hun Suh.   

Abstract

Stem cell therapy has been noted as a novel strategy to various diseases including neurological disorders such as Alzheimer's disease, Parkinson's disease, stroke, amyotrophic lateral sclerosis, and Huntington's disease that have no effective treatment available to date. The adipose-derived stem cells (ASCs), mesenchymal stem cells (MSCs) isolated from adipose tissue, are well known for their pluripotency with the ability to differentiate into various types of cells and immuno-modulatory property. These biological features make ASCs a promising source for regenerative cell therapy in neurological disorders. Here we discuss the recent progress of regenerative therapies in various neurological disorders utilizing ASCs.

Entities:  

Mesh:

Year:  2014        PMID: 25409785     DOI: 10.1254/jphs.14R10CP

Source DB:  PubMed          Journal:  J Pharmacol Sci        ISSN: 1347-8613            Impact factor:   3.337


  15 in total

1.  Gene therapy with mesenchymal stem cells expressing IFN-ß ameliorates neuroinflammation in experimental models of multiple sclerosis.

Authors:  C Marin-Bañasco; K Benabdellah; C Melero-Jerez; B Oliver; M J Pinto-Medel; I Hurtado-Guerrero; F de Castro; D Clemente; O Fernández; F Martin; L Leyva; M Suardíaz
Journal:  Br J Pharmacol       Date:  2017-01-12       Impact factor: 8.739

2.  Fibroblast Growth Factor 1-Transfected Adipose-Derived Mesenchymal Stem Cells Promote Angiogenic Proliferation.

Authors:  Seyed Javad Hoseini; Hamed Ghazavi; Fatemeh Forouzanfar; Baratali Mashkani; Ahmad Ghorbani; Elahe Mahdipour; Faezeh Ghasemi; Hamid Reza Sadeghnia; Majid Ghayour-Mobarhan
Journal:  DNA Cell Biol       Date:  2017-03-10       Impact factor: 3.311

3.  Effects of induced pluripotent stem cells-derived conditioned medium on the proliferation and anti-apoptosis of human adipose-derived stem cells.

Authors:  Rui-Ling Lian; Xiao-Ling Guo; Jian-Su Chen; Yong-Long Guo; Jia-Fu Zheng; Yuan-Wen Chen
Journal:  Mol Cell Biochem       Date:  2016-01-02       Impact factor: 3.396

Review 4.  Stem cell-based therapy as a promising approach in Alzheimer's disease: current perspectives on novel treatment.

Authors:  Saeid Bagheri-Mohammadi
Journal:  Cell Tissue Bank       Date:  2021-01-04       Impact factor: 1.522

Review 5.  Mesenchymal stem cells in neurodegenerative diseases: Opinion review on ethical dilemmas.

Authors:  Matteo Scopetti; Alessandro Santurro; Vittorio Gatto; Raffaele La Russa; Federico Manetti; Stefano D'Errico; Paola Frati; Vittorio Fineschi
Journal:  World J Stem Cells       Date:  2020-03-26       Impact factor: 5.326

6.  Intraarterial transplantation of human umbilical cord blood mononuclear cells in hyperacute stroke improves vascular function.

Authors:  Lei Huang; Yichu Liu; Jianfei Lu; Bianca Cerqueira; Vivek Misra; Timothy Q Duong
Journal:  Stem Cell Res Ther       Date:  2017-03-22       Impact factor: 6.832

Review 7.  Current Perspectives regarding Stem Cell-Based Therapy for Alzheimer's Disease.

Authors:  Kyeong-Ah Kwak; Seung-Pyo Lee; Jin-Young Yang; Young-Seok Park
Journal:  Stem Cells Int       Date:  2018-03-01       Impact factor: 5.443

8.  Therapeutic Potential of Human Turbinate-Derived Mesenchymal Stem Cells in Experimental Acute Ischemic Stroke.

Authors:  Hyosun Lim; Sun Hwa Park; Sung Won Kim; Kyung-Ok Cho
Journal:  Int Neurourol J       Date:  2018-10-31       Impact factor: 2.835

Review 9.  Mesenchymal stromal cells as a potential therapeutic for neurological disorders.

Authors:  Takeo Mukai; Arinobu Tojo; Tokiko Nagamura-Inoue
Journal:  Regen Ther       Date:  2018-08-24       Impact factor: 3.419

10.  Effects of intra-arterial transplantation of adipose-derived stem cells on the expression of netrin-1 and its receptor DCC in the peri-infarct cortex after experimental stroke.

Authors:  Huan Huang; Fan Lin; Jingjing Jiang; Yan Chen; Ainong Mei; Pengli Zhu
Journal:  Stem Cell Res Ther       Date:  2017-10-10       Impact factor: 6.832

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.